Table 2 Descriptive sample characteristics: group comparisons in terms of the BMI

From: Association between serum neuron-specific enolase, age, overweight, and structural MRI patterns in 901 subjects

 

BMI <25 N/mean

±SD or (%)

BMI ≥25 N/mean

±SD or (%)

p value

Participants

302

(33.5)

599

(66.5)

 

Sex

    

<0.001

 Women

203

(40.7)

296

(59.3)

 

 Men

99

(24.6)

303

(75.4)

 

Age (y)

44.95

±13.4

53.0

±12.8

<0.001

NSE (µg/L)

9.0

±3.6

8.8

±3.7

0.407

GMV (cm3)*

590.4

±66.5

576.8

±63.2

0.004

WC (cm)

76.2

±7.2

93.7

±10.6

<0.001

WC ≥88 (cm), women

1

(0.7)

147

(99.3)

<0.001

WC ≥102 (cm), men

0

(0.0)

104

(100.0)

<0.001

Systolic BP in mmHg

116.4

±13.9

128.4

±16.4

<0.001

Diastolic BP in mmHg

72.4

±8.2

78.6

±9.6

<0.001

Hypertension

45

(12.6)

312

(87.4)

<0.001

Smoking nicotine

    

0.013

 Current

72

(23.8)

118

(19.7)

 

 Former

89

(29.5)

236

(39.4)

 

 Never

140

(46.4)

244

(40.7)

 

Triglycerides in mmol/L

1.0

±0.4

1.6

±1.0

<0.001

LDL-C in mmol/L

3.1

±0.9

3.5

±0.9

<0.001

HDL-C in mmol/L

1.6

±0.4

1.4

±0.3

<0.001

Total cholesterol in mmol/L

5.3

±1.0

5.6

±1.0

<0.001

Antihypertensives

33

(12.6)

229

(87.4)

<0.001

Lipid-lowering drugs

6

(8.6)

64

(91.4)

<0.001

  1. BMI body mass index, BP blood pressure, GMV gray matter volume, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, NSE neuron-specific enolase, WC waist circumference, y years
  2. *Data available for 832 subjects; bold values represent statistical significant p-values defined as p < 0.05